Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InstaMed, a J.P. Morgan company, is a leading healthcare payments network that simplifies the clearinghouse and payment transaction process for providers, payers, and consumers. Founded in 2004, the company offers a patented, private cloud-based platform that securely drives electronic transactions, processes payments, and moves healthcare data seamlessly. InstaMed's solutions integrate with leading electronic health records (EHR) and practice management systems to enable omnichannel payment options, reduce collection costs, and eliminate paper billing. Acquired by JPMorgan Chase in 2019 for over $500 million, InstaMed continues to operate as a key component of the bank's wholesale payments division, serving thousands of hospitals, practices, and billing services nationwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instamed.